Inventor · disambiguated record
Christopher Allen Ziebenhaus
Also filed as: ZIEBENHAUS CHRISTOPHER A · ZIEBENHAUS CHRISTOPHER ALLEN
10 granted patents·2 pending applications·14 citations·filing 2017–2025
82Inventor score
Files withGILEAD SCIENCES INC12
Top patents by PatentIndex Score
12 records- 0193US10774071B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Sep 15, 2020·7 cites·18 claims
- 0291US10710986B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 14, 2020·4 cites·5 claims
- 0389US11453681B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Sep 27, 2022·2 cites·53 claims
- 0483US11555029B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jan 17, 2023·1 cites·9 claims
- 0578US2025270195A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 0677US12338233B2PD-1/Pd-L1 inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Jun 24, 2025·0 cites·4 claims
- 0770US12037342B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Jul 16, 2024·0 cites·54 claims
- 0860US12269812B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 8, 2025·0 cites·11 claims
- 0948US2018305315A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 1047US10899735B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jan 26, 2021·0 cites·9 claims
- 1146US11236085B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Feb 1, 2022·0 cites·28 claims
- 1242US10100058B2Fused heterocyclic compounds as CaM kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Granted Oct 16, 2018·0 cites·33 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Allen Ziebenhaus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →